SCHEMBL7554044

SCHEMBL7554044

CC(O)C(N)CCN(C)C

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33
HTR2A P28223 1/20 0.32
HRH1 P35367 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
TRPA1 O75762 1/20 0.32
ANPEP P15144 1/20 0.31
CFD P00746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11328208 0.86 ALDH1A1 (0.38) MAPTHTR2AHRH1TRPV1TRPA1
SCHEMBL10520849 0.79 HTR2A (0.39) MAPTHTR2AHRH1CFD
SCHEMBL10421630 0.79 HTR2A (0.34) MAPTHTR2AHRH1CFD
SCHEMBL3584670 0.76
SCHEMBL17360706 0.75 MAPT (0.33) MAPTHTR2AHRH1TRPV1TRPA1
SCHEMBL7999410 0.75
SCHEMBL5886507 0.74
SCHEMBL5886313 0.74
SCHEMBL3714888 0.73
SCHEMBL21563870 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128421-A1 Curable compositions SHELVEY MICHAEL FRANCIS (GB) 2002-09-12 US claimed
EP-0850256-B1 CURABLE COMPOSITIONS BSN MEDICAL INC (US) 2002-07-17 EP claimed
US-20010005744-A1 CURABLE COMPOSITIONS BSN MEDICAL, INC. 2001-06-28 US claimed
US-20020128421-A1 Curable compositions SHELVEY MICHAEL FRANCIS (GB) 2002-09-12 US disclosed
EP-0850256-B1 CURABLE COMPOSITIONS BSN MEDICAL INC (US) 2002-07-17 EP disclosed
US-20010005744-A1 CURABLE COMPOSITIONS BSN MEDICAL, INC. 2001-06-28 US disclosed